QuintilesIMS Blog

Fresh ideas and insights from our experts around the globe

Brazilians flock to pharmacies: How healthcare companies can bolster sales by embracing this shifting shopper trend
Filtered by 'Outsourcing' ×
Vishal Khanna
How collaborating for downstream commercial activities can drive value, agility, and optimize business operations across the biopharma commercial organization.
Read More
Paul Harney
How outsourcing to a multi-dimensional partner can cut the time and cost of commercial launches, while giving emerging biotech companies greater flexibility to grow.
Read More
Ross Horsburgh
How automation and centralization can cut the time, cost and risk from these regulatory oversight tasks.
Read More
How an integrated supply chain management approach cuts time, saves money and makes for happy investigators and patients.
Read More
Glenn Potvin
Why biopharma should be concerned about their manufacturing partners and themselves.
Read More
George Esrgo
Peter DiBiaso
When it comes to planning and managing the execution of clinical trials, the project manager is like a CEO, leveraging necessary resources and making critical decisions. This is especially true when working with mid-market biopharmaceutical sponsor companies. These organizations are in a rapid growth phase and typically have a targeted portfolio of assets under development. They are often still building out best practices and standard operating procedures, and frequently rely on their outsourcing providers to fill gaps and share their extensive experience to optimize development success. In doing so, they face the daunting challenge of choosing a provider who not only has the expertise to meet their clinical needs, but also the right cultural fit and ability to perform as a partner...
Read More